Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

BACKGROUND: Sitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While studies conducted in other countries have...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kim, Soon Ae, Shim, Woo Ho, Lee, Eun Hae, Lee, Young Mi, Beom, Sun Hee, Kim, Eun Sook, Yoo, Jeong Seon, Nam, Ji Sun, Cho, Min Ho, Park, Jong Suk, Ahn, Chul Woo, Kim, Kyung Rae
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Diabetes Association 2011
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122893/
https://ncbi.nlm.nih.gov/pubmed/21738898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2011.35.2.159
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk